Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
PharmAbcine to Participate in Biotechgate Digital Partnering 2021-08-17 20:00
Innoforce Pharmaceuticals Opens Analytical Development and Process Development Facility in Hangzhou, China 2021-08-17 19:00
SINOMED announces the first commercial implantation and European launch of the HT Supreme Drug Eluting Stent 2021-08-17 18:00
Angel Pharmaceuticals Announces IND Acceptance for Clinical Trial of ITK Inhibitor CPI-818 in China 2021-08-17 05:00
111, Inc. Deepens Partnership with Bayer Healthcare 2021-08-16 20:00
Gracell Biotechnologies Signs Exclusive License Agreement with FutureGen Biopharm to Develop Engineered Immune Cell Therapies Targeting Claudin 18.2 in Solid Tumors 2021-08-16 20:00
Senhwa Completes Enrollment of a Phase 2 Investigator Initiated Trial of Silmitasertib as Novel Oral Drug for COVID-19 2021-08-16 15:29
Sino Biological Announces Successful Closing of 4.98 Billion RMB Public Offering and Listing on the Shenzhen ChiNext Stock Exchange 2021-08-16 13:12
InnoCare Announces First Subject Dosed in Clinical Trial of ICP-332 2021-08-16 09:32
InxMed's IN10018 Receives U.S. FDA Fast Track Designation for the Treatment of Platinum-resistant Ovarian Cancer 2021-08-16 09:31
Arctic Vision Announces Expansion of License Territory for Suprachoroidal Space Injection Therapy ARVN001 to Include ASEAN Countries and India 2021-08-16 08:00
Innovent Announces Sintilimab in Combination with Chemotherapy Meets the Primary Endpoint of Overall Survival in the Phase 3 ORIENT-16 Study for the First-Line Treatment of Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma 2021-08-16 08:00
Senhwa Signs Agreement with Taiwan's CDE for COVID-19 Program Guiding Development of Silmitasertib 2021-08-14 10:48
Diabetes treatment lowers PromarkerD risk score for diabetic kidney disease 2021-08-12 21:30
Cali Biosciences Initiates Phase 2b Study of Long-Acting Ropivacaine for Non-Opioid Treatment of Post-Operative Pain 2021-08-12 10:28
Innovent Announces IBI306 (anti-PCSK-9 antibody) Meets the Primary Endpoint in a Phase 3 Clinical Study for Chinese Heterozygous Familial Hypercholesterolemia 2021-08-12 08:00
Lynk Pharmaceuticals Announced First Patient Dosed in Phase I Clinical Study of Its Triple-Kinase Inhibitor LNK01002 2021-08-12 08:00
VolitionRx Limited Announces Second Quarter 2021 Financial Results and Business Update 2021-08-12 04:10
The Former Director of the Center for Drug Evaluation and Research at FDA and R&D Leader at Amgen, Steven Galson Joins Insilico Medicine as Independent Director 2021-08-11 20:31
ImmVira's MVR-T3011 IV Completed First Dosing for Intravenous Administration in a U.S. Phase I Clinical Trial 2021-08-11 10:45
1 229 230 231 232 233 413